| Literature DB >> 27614428 |
Kentaro Miki1, Yorihisa Orita2, Yuka Gion3, Soshi Takao4, Kyotaro Ohno3, Mai Takeuchi3, Toshihiro Ito5, Hiroyuki Hanakawa6, Tomoyasu Tachibana7, Hidenori Marunaka8, Takuma Makino7, Akira Minoura9, Akihiro Matsukawa10, Kazunori Nishizaki1, Tadashi Yoshino3, Yasuharu Sato3,11.
Abstract
The objective of this study was to observe the distribution of regulatory T cells (Tregs) in the development of tongue squamous cell carcinoma (SCC) and to determine the role of Tregs in the progression of tongue SCC. A mouse model of 4-nitroquinoline-1-oxide (4NQO)-induced-tongue SCC was established. The expression of Forkhead box P3 (Foxp3), interleukin 10, transforming growth factor-β, chemokine CC motif ligands 17, 20, and CC chemokine receptor 4 was determined using real-time quantitative polymerase chain reaction. Foxp3 expression was also analyzed using immunohistochemistry. The results were compared with those of control mice and of 4NQO-treated mice treated with a cyclooxygenase-2 (COX-2) inhibitor. Well to moderately differentiated tongue SCC was induced in all of the experimental mice. The amount of Tregs of the experimental mice was over 10 times as much as control mice at the early stage of tumor progression. COX-2 inhibitor did not prevent the progression of tongue SCC and did not reduce the total amount of Tregs. Tregs function at the early stage of the development of tongue SCC, and it may be effective to suppress Tregs at the early stage of tumor progression for the treatment and/or prevention of tongue SCC.Entities:
Keywords: Foxp3; IL-10; Regulatory T cell; TGF-β; Tongue squamous cell carcinoma
Mesh:
Substances:
Year: 2016 PMID: 27614428 DOI: 10.1007/s00262-016-1902-x
Source DB: PubMed Journal: Cancer Immunol Immunother ISSN: 0340-7004 Impact factor: 6.968